Intensity Therapeutics Inc.
07/17/2024 | Press release | Distributed by Public on 07/17/2024 14:02
Submission of Matters to a Vote of Security Holders Form 8 K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July 17, 2024, Intensity Therapeutics, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") via live webcast. At the Annual Meeting, the stockholders of the Company approved the Company's 2024 Employee Stock Purchase Plan (the "ESPP").
A summary of the ESPP was included in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 4, 2024 under the section entitled "Proposal 2: Approval of the Intensity Therapeutics, Inc. 2024 Employee Stock Purchase Plan" and is incorporated herein by reference. This summary is qualified in its entirety by reference to the ESPP, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8 K.